Ending HIV Transmission in Australia: Expanding PrEP to Cisgender Women: A Scoping Review

Pre-exposure prophylaxis (PrEP) availability through the Pharmaceutical Benefits Scheme provides real potential for the elimination of HIV transmission in Australia, as evidenced by a rapid decline in HIV incidence among gay and bisexual men (GBM).

However, HIV elimination will not be possible without also extending PrEP to other populations, including cisgender women.

We conducted a scoping review to examine the extent to which PrEP access for cisgender women has been considered in Australia.

A comprehensive search across five databases, grey literature, and hand search of references was conducted.

A single reviewer conducted title and abstract screening and two reviewers completed full-text screening and data extraction.

Nineteen documents were included in the final review and included both peer-reviewed journal articles and guidelines and strategies.

Focused discussion of cisgender women’s use of PrEP was largely missing from the literature and, although their use of PrEP is supported in some relevant guidelines, little has been done to actively develop strategies to inform cisgender women about PrEP as a precursor to prescribing for HIV prevention.

Healthcare providers’ narrow view of PrEP as being the domain of GBM further limits cisgender women’s potential access.

If HIV elimination in Australia is to be a reality, we need to develop mechanisms to specifically engage with cisgender women about PrEP.